ACRS - Aclaris Therapeutics EPS misses by $0.29 beats on revenue May, 07 2021 07:39 AM Aclaris Therapeutics Inc. Aclaris Therapeutics (ACRS): Q1 GAAP EPS of -$0.57 misses by $0.29.Revenue of $1.78M (+26.2% Y/Y) beats by $0.3M.Press Release For further details see: Aclaris Therapeutics EPS misses by $0.29, beats on revenue